ARCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,294,510.00

Arcturus Therapeutics Insider Trading History Chart

Arcturus Therapeutics Share Price & Price History

^$11.58

▼ -0.42 (-3.50%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Arcturus Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/15/2024	Pad Chivukula	COO	Sell	12,000	$20.76	$249,120.00	435,334
6/5/2024	Pad Chivukula	COO	Sell	114	$45.00	$5,130.00	447,334
6/3/2024	Pad Chivukula	COO	Sell	26,000	$40.01	$1,040,260.00	447,448
3/25/2024	Pad Chivukula	COO	Sell	17,435	$35.02	$610,573.70	473,448
3/19/2024	Pad Chivukula	COO	Sell	8,565	$35.01	$299,860.65	490,883
11/1/2023	Pad Chivukula	COO	Sell	5,000	$18.72	$93,600.00	499,448
10/2/2023	Pad Chivukula	COO	Sell	5,000	$25.61	$128,050.00	504,448
9/1/2023	Pad Chivukula	COO	Sell	5,000	$31.45	$157,250.00	509,448
7/14/2023	Keith C Kummerfeld	Insider	Sell	6,968	$35.00	$243,880.00	950
7/14/2023	Pad Chivukula	COO	Sell	25,000	$35.01	$875,250.00	519,448
7/3/2023	Pad Chivukula	COO	Sell	5,000	$28.75	$143,750.00	544,448
5/10/2023	Pad Chivukula	COO	Sell	17,075	$30.00	$512,250.00	562,373
5/1/2023	Pad Chivukula	COO	Sell	5,000	$25.93	$129,650.00	579,448
4/18/2023	Keith C Kummerfeld	Insider	Sell	6,968	$28.18	$196,358.24	950
4/3/2023	Pad Chivukula	COO	Sell	5,000	$25.38	$126,900.00	584,448
3/6/2023	Pad Chivukula	COO	Sell	5,000	$16.07	$80,350.00	589,448
12/15/2022	Magda Marquet	Director	Buy	2,222	$18.00	$39,996.00	24,942

See Full Table

SEC Filings (Institutional Ownership Changes) for Arcturus Therapeutics (NASDAQ:ARCT)

94.54% of Arcturus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arcturus Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	52,189	$0.89M	0.0%	-74.6%	0.193%
2/17/2025	Woodline Partners LP	806,912	$13.69M	0.1%	+3.5%	2.979%
2/17/2025	Squarepoint Ops LLC	10,102	$0.17M	0.0%	-69.3%	0.037%
2/17/2025	Two Sigma Investments LP	27,560	$0.47M	0.0%	+60.9%	0.102%
2/17/2025	Sherbrooke Park Advisers LLC	11,786	$0.20M	0.1%	N/A	0.044%
2/17/2025	Rafferty Asset Management LLC	57,592	$0.98M	0.0%	-11.7%	0.213%
2/17/2025	MPM Bioimpact LLC	459,943	$7.81M	1.1%	+109.5%	1.698%
2/17/2025	Man Group plc	21,968	$0.37M	0.0%	-15.9%	0.081%
2/17/2025	Nuveen Asset Management LLC	87,097	$1.48M	0.0%	-10.5%	0.322%
2/17/2025	Lazard Asset Management LLC	6,690	$0.11M	0.0%	-25.6%	0.025%
2/17/2025	J. Goldman & Co LP	296,045	$5.02M	0.1%	N/A	1.093%
2/17/2025	Jacobs Levy Equity Management Inc.	119,558	$2.03M	0.0%	+19.9%	0.441%
2/17/2025	Deutsche Bank AG	24,768	$0.42M	0.0%	+42.7%	0.091%
2/17/2025	Cresset Asset Management LLC	11,511	$0.20M	0.0%	-16.0%	0.042%
2/17/2025	Brevan Howard Capital Management LP	12,305	$0.21M	0.0%	+13.7%	0.045%
2/17/2025	Balyasny Asset Management L.P.	548,761	$9.31M	0.0%	N/A	2.026%
2/17/2025	Bank of America Corp DE	27,712	$0.47M	0.0%	-82.5%	0.102%
2/17/2025	BNP Paribas Financial Markets	2,738	$46K	0.0%	-82.7%	0.010%
2/17/2025	Ameriprise Financial Inc.	18,613	$0.32M	0.0%	+5.0%	0.069%
2/14/2025	PDT Partners LLC	90,298	$1.53M	0.1%	+20.2%	0.333%
2/14/2025	Schonfeld Strategic Advisors LLC	849,081	$14.41M	0.1%	+129.7%	3.134%
2/14/2025	Northern Trust Corp	256,332	$4.35M	0.0%	+5.6%	0.946%
2/14/2025	Boothbay Fund Management LLC	58,944	$1M	0.0%	N/A	0.218%
2/14/2025	Virtus ETF Advisers LLC	4,051	$69K	0.0%	+38.8%	0.015%
2/14/2025	Price T Rowe Associates Inc. MD	19,018	$0.32M	0.0%	+7.2%	0.070%
2/14/2025	MGO One Seven LLC	41,350	$0.70M	0.0%	+5.6%	0.153%
2/14/2025	Hsbc Holdings PLC	25,368	$0.42M	0.0%	+11.8%	0.094%
2/14/2025	MetLife Investment Management LLC	16,676	$0.28M	0.0%	+21.5%	0.062%
2/14/2025	Dimensional Fund Advisors LP	707,404	$12M	0.0%	-10.7%	2.612%
2/13/2025	Jump Financial LLC	58,308	$0.99M	0.0%	-4.0%	0.215%
2/13/2025	Barclays PLC	60,082	$1.02M	0.0%	-10.9%	0.222%
2/13/2025	Kennedy Capital Management LLC	10,987	$0.19M	0.0%	+22.7%	0.041%
2/13/2025	Legal & General Group Plc	24,147	$0.41M	0.0%	-8.0%	0.089%
2/13/2025	Wells Fargo & Company MN	69,664	$1.18M	0.0%	+12.6%	0.257%
2/12/2025	Massachusetts Financial Services Co. MA	59,817	$1.02M	0.0%	+22.2%	0.221%
2/12/2025	Geode Capital Management LLC	554,984	$9.42M	0.0%	+0.6%	2.049%
2/12/2025	National Bank of Canada FI	5,532	$94K	0.0%	+639.6%	0.020%
2/12/2025	Franklin Resources Inc.	100,677	$1.71M	0.0%	-3.1%	0.372%
2/12/2025	Wellington Management Group LLP	97,036	$1.65M	0.0%	+0.8%	0.358%
2/12/2025	Blair William & Co. IL	16,735	$0.28M	0.0%	-6.1%	0.062%
2/12/2025	JPMorgan Chase & Co.	236,368	$4.01M	0.0%	-7.9%	0.873%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	13,461	$0.24M	0.0%	+52.7%	0.050%
2/11/2025	Corebridge Financial Inc.	11,389	$0.19M	0.0%	-7.0%	0.042%
2/11/2025	Vanguard Group Inc.	1,684,561	$28.59M	0.0%	+6.8%	6.218%
2/11/2025	LPL Financial LLC	11,496	$0.20M	0.0%	-6.6%	0.042%
2/11/2025	KLP Kapitalforvaltning AS	4,200	$71K	0.0%	N/A	0.016%
2/11/2025	American Century Companies Inc.	47,018	$0.80M	0.0%	+10.7%	0.174%
2/10/2025	Tocqueville Asset Management L.P.	22,400	$0.38M	0.0%	+42.7%	0.083%
2/10/2025	Nikko Asset Management Americas Inc.	2,065,050	$34.94M	0.4%	-10.8%	7.623%
2/10/2025	Commonwealth Equity Services LLC	16,616	$0.28M	0.0%	-10.9%	0.061%
2/10/2025	Jupiter Asset Management Ltd.	319,446	$5.42M	0.1%	-9.2%	1.179%
2/7/2025	AlphaQuest LLC	7,142	$0.12M	0.0%	-63.9%	0.026%
2/7/2025	Bank Julius Baer & Co. Ltd Zurich	2,084	$39K	0.0%	-91.8%	0.008%
2/6/2025	Charles Schwab Investment Management Inc.	207,802	$3.53M	0.0%	+5.2%	0.767%
2/4/2025	ARK Investment Management LLC	1,933,851	$32.82M	0.3%	-8.0%	7.139%
2/4/2025	Bank of New York Mellon Corp	78,180	$1.33M	0.0%	-22.0%	0.289%
1/30/2025	Empire Life Investments Inc.	279,463	$4.74M	0.3%	+85.5%	1.032%
1/28/2025	Sumitomo Mitsui Trust Group Inc.	2,065,050	$35.04M	0.0%	-9.3%	7.623%
1/24/2025	Spire Wealth Management	13,478	$0.23M	0.0%	+393.3%	0.050%
1/17/2025	SG Americas Securities LLC	11,940	$0.20M	0.0%	+45.0%	0.044%
1/15/2025	Hennion & Walsh Asset Management Inc.	82,057	$1.39M	0.1%	+139.7%	0.303%
1/6/2025	Nordea Investment Management AB	65,778	$1.10M	0.0%	+3.7%	0.243%
11/27/2024	Franklin Resources Inc.	103,936	$2.41M	0.0%	+54.6%	0.384%
11/16/2024	Geode Capital Management LLC	551,798	$12.81M	0.0%	+1.1%	2.037%
11/15/2024	XTX Topco Ltd	36,990	$0.86M	0.1%	+51.1%	0.137%
11/15/2024	Wellington Management Group LLP	96,294	$2.24M	0.0%	-73.3%	0.355%
11/15/2024	State Street Corp	1,472,955	$34.19M	0.0%	-3.3%	5.437%
11/15/2024	Point72 DIFC Ltd	1,210	$28K	0.0%	-84.3%	0.004%
11/15/2024	Portolan Capital Management LLC	129,144	$3M	0.2%	-73.4%	0.477%
11/15/2024	Jacobs Levy Equity Management Inc.	99,699	$2.31M	0.0%	-0.6%	0.368%
11/14/2024	PDT Partners LLC	75,144	$1.74M	0.2%	N/A	0.277%
11/14/2024	Verition Fund Management LLC	18,113	$0.42M	0.0%	N/A	0.067%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	8,694	$0.20M	0.0%	+10.8%	0.032%
11/13/2024	BNP Paribas Financial Markets	15,831	$0.37M	0.0%	+954.7%	0.058%
11/13/2024	FMR LLC	443,008	$10.28M	0.0%	-20.3%	1.635%
11/12/2024	Charles Schwab Investment Management Inc.	197,622	$4.59M	0.0%	+1.7%	0.730%
11/12/2024	Massachusetts Financial Services Co. MA	48,957	$1.14M	0.0%	+28.1%	0.181%
11/7/2024	Quest Partners LLC	19,810	$0.46M	0.0%	+437.1%	0.074%
11/6/2024	Royce & Associates LP	155,803	$3.62M	0.0%	+18.3%	0.579%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	2,275,715	$52.82M	0.0%	+45.6%	8.450%
11/5/2024	GSA Capital Partners LLP	9,417	$0.22M	0.0%	-84.7%	0.035%
11/4/2024	Los Angeles Capital Management LLC	23,433	$0.54M	0.0%	N/A	0.087%
10/31/2024	ARK Investment Management LLC	2,101,038	$48.77M	0.4%	+6.9%	7.801%
10/29/2024	Empire Life Investments Inc.	150,692	$3.50M	0.2%	N/A	0.560%
10/29/2024	Harbor Capital Advisors Inc.	42,635	$0.99M	0.0%	-35.1%	0.158%
10/25/2024	China Universal Asset Management Co. Ltd.	5,201	$0.12M	0.0%	+64.4%	0.019%
10/16/2024	nVerses Capital LLC	1,800	$42K	0.0%	N/A	0.007%
10/16/2024	Vontobel Holding Ltd.	29,735	$0.69M	0.0%	-3.2%	0.110%
10/3/2024	SG Americas Securities LLC	8,235	$0.19M	0.0%	N/A	0.031%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	5,852	$0.14M	0.0%	N/A	0.022%
8/19/2024	Point72 Asset Management L.P.	244,154	$5.95M	0.0%	-27.2%	0.907%
8/15/2024	Scientech Research LLC	15,377	$0.37M	0.1%	N/A	0.057%
8/15/2024	Millennium Management LLC	555,024	$13.52M	0.0%	+250.1%	2.061%
8/15/2024	Deerfield Management Company L.P. Series C	39,328	$0.96M	0.0%	N/A	0.146%
8/15/2024	AQR Capital Management LLC	11,700	$0.29M	0.0%	-84.2%	0.043%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	5,852	$0.14M	0.0%	N/A	0.022%
8/14/2024	Squarepoint Ops LLC	29,499	$0.72M	0.0%	N/A	0.110%
8/14/2024	Point72 DIFC Ltd	7,713	$0.19M	0.0%	N/A	0.029%
8/14/2024	Marshall Wace LLP	45,219	$1.10M	0.0%	-46.3%	0.168%
8/14/2024	Profund Advisors LLC	14,309	$0.35M	0.0%	-40.9%	0.053%

Data available starting January 2016

See Full Table

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. Its product pipeline includes, ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3; ARCT-2303 for monovalent that is in Phase 3; ARCT-2138 for quadrivalent which is in Phase 1; and LUNAR-FLU which is in pre-clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Today's Range

Now: $11.58

$11.39

$12.10

50 Day Range

MA: $15.61

$11.58

$18.05

52 Week Range

Now: $11.58

$11.39

$45.00

Volume

311,032 shs

Average Volume

454,385 shs

Market Capitalization

$314.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.96

Who are the company insiders with the largest holdings of Arcturus Therapeutics?: Arcturus Therapeutics' top insider shareholders include:
Pad Chivukula (COO)
Keith C Kummerfeld (Insider)
Learn More about top insider investors at Arcturus Therapeutics.
Who are the major institutional investors of Arcturus Therapeutics?: Arcturus Therapeutics' top institutional investors include:
Sumitomo Mitsui Trust Group Inc. — 7.62%
Nikko Asset Management Americas Inc. — 7.62%
ARK Investment Management LLC — 7.14%
Vanguard Group Inc. — 6.22%
Schonfeld Strategic Advisors LLC — 3.13%
Woodline Partners LP — 2.98%
Learn More about top institutional investors of Arcturus Therapeutics stock.
Which major investors are selling Arcturus Therapeutics stock?: Within the last quarter, ARCT stock was sold by these institutional investors:
Nikko Asset Management Americas Inc.
Sumitomo Mitsui Trust Group Inc.
ARK Investment Management LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Bank of America Corp DE
Dimensional Fund Advisors LP
Jupiter Asset Management Ltd.
Bank Julius Baer & Co. Ltd Zurich
Which major investors are buying Arcturus Therapeutics stock?: In the last quarter, ARCT stock was purchased by institutional investors including:
Balyasny Asset Management L.P.
Schonfeld Strategic Advisors LLC
J. Goldman & Co LP
MPM Bioimpact LLC
Empire Life Investments Inc.
Vanguard Group Inc.
Boothbay Fund Management LLC
Hennion & Walsh Asset Management Inc.